BioMed Research International / 2019 / Article / Tab 1 / Research Article
The Effects of Once-Weekly Dulaglutide and Insulin Glargine on Glucose Fluctuation in Poorly Oral-Antidiabetic Controlled Patients with Type 2 Diabetes Mellitus Table 1 Clinical characteristics.
Dulaglutide group ( ) Glargine group ( ) Sex (female%) Baseline 6 (37.50%) 4 (44.44%) 1 History (years) Baseline 8 (5, 14.5) 5(3, 11.5) −1.08 0.293 Age (years) Baseline 59.88 ± 8.17 65.44 ± 11.09 −1.438 0.164 Height (cm) Baseline 165.13 ± 7.48 159.44 ± 6.21 1.93 0.066 Weight (kg) Baseline 68.97 ± 10.13 62.56 ± 5.72 2.023 0.055 52w 69.06 ± 9.85 64.67 ± 6.20 1.205 0.24 Body mass index (kg/m2 ) Baseline 25.22 ± 2.67 24.63 ± 2.12 0.57 0.574 52w 25.26 ± 2.53 25.46 ± 2.30 −0.198 0.845 Systolic BP (mmHg) Baseline 134.38 ± 13.93 133.67 ± 11.94 0.128 0.899 52w 134.69 ± 16.91 135.44 ± 10.00 −0.122 0.904 Diastolic BP (mmHg) Baseline 80.06 ± 8.65 77.44 ± 8.53 0.73 0.473 52w 82.38 ± 8.98 77.89 ± 8.59 1.217 0.236 Heart rate (bpm) Baseline 78.56 ± 7.20 73.33 ± 6.75 1.781 0.088 52w 77.50 ± 6.76 75.44 ± 11.25 0.574 0.571 Corrected QT interval Baseline 438.52 ± 27.42 431.90 ± 18.22 0.636 0.531 52w 437.00 ± 26.59 427.44 ± 25.41 0.876 0.39
BP: blood pressure.